[S3-Guidelines "Exocrine pancreatic cancer" 2007].

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMID 17607616)

Published in Z Gastroenterol on June 01, 2007

Authors

G Adler1, T Seufferlein, S C Bischoff, H-J Brambs, S Feuerbach, G Grabenbauer, S Hahn, V Heinemann, W Hohenberger, J M Langrehr, M P Lutz, O Micke, H Neuhaus, P Neuhaus, H Oettle, P M Schlag, R Schmid, W Schmiegel, K Schlottmann, J Werner, B Wiedenmann, I Kopp

Author Affiliations

1: Klinik für Innere Medizin I, Universitätsklinikum Ulm, Ulm. guido.adler@uniklinik-ulm.de

Articles citing this

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med (2010) 4.13

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol (2012) 1.28

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study. Br J Cancer (2009) 1.10

Pancreatic cancer--low survival rates. Dtsch Arztebl Int (2008) 0.98

Blood group determinates incidence for pancreatic cancer in Germany. Front Physiol (2013) 0.96

Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial. Strahlenther Onkol (2014) 0.91

Splenic artery use for arterial reconstruction in pancreatic surgery. Langenbecks Arch Surg (2014) 0.87

Postoperative care following pancreatic surgery: surveillance and treatment. Dtsch Arztebl Int (2009) 0.84

Pancreatic resections for advanced M1-pancreatic carcinoma: the value of synchronous metastasectomy. HPB Surg (2010) 0.84

Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy. Saudi J Gastroenterol (2012) 0.83

Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV). Case Rep Oncol (2011) 0.82

Comparative analysis of ERCP, IDUS, EUS and CT in predicting malignant bile duct strictures. World J Gastroenterol (2014) 0.82

Pancreatoduodenectomy--current status of surgical and perioperative techniques in Germany. Langenbecks Arch Surg (2013) 0.82

Improving outcomes in pancreatic cancer: key points in perioperative management. World J Gastroenterol (2014) 0.81

Current state of surgical management of pancreatic cancer. Cancers (Basel) (2011) 0.79

Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC. BMC Cancer (2012) 0.79

A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2. BMC Cancer (2009) 0.78

Surgical treatment concepts for patients with pancreatic cancer in Germany--results from a national survey conducted among members of the "Chirurgische Arbeitsgemeinschaft Onkologie" (CAO) and the "Arbeitsgemeinschaft Internistische Onkologie" (AIO) of the Germany Cancer Society (DKG). Langenbecks Arch Surg (2010) 0.77

[Update of the S3 guidelines for pancreatic cancer. What is new for pathologists?]. Pathologe (2014) 0.77

The Pancreas: Causes for Malabsorption. Viszeralmedizin (2014) 0.76

[Resection plus adjuvant chemotherapy improves survival in advanced pancreatic adenocarcinoma]. Strahlenther Onkol (2013) 0.75

An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2nd or higher line chemotherapy regarding clinical benefit - PANUSCO. BMC Cancer (2009) 0.75

Gemcitabine more useful. Dtsch Arztebl Int (2008) 0.75

Quality Assurance in Endoscopy: Which Parameters? Visc Med (2016) 0.75

[New aspects of surgery for pancreatic cancer. Principles, results and evidence]. Pathologe (2012) 0.75

Articles by these authors

Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol (2001) 11.41

Five intermediate complexes in transcription initiation by RNA polymerase II. Cell (1989) 9.22

Crystal structure of a yeast TBP/TATA-box complex. Nature (1993) 7.95

The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A (1968) 6.96

Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell (1985) 6.06

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86

Ageing, fitness and neurocognitive function. Nature (1999) 5.58

An operator at -280 base pairs that is required for repression of araBAD operon promoter: addition of DNA helical turns between the operator and promoter cyclically hinders repression. Proc Natl Acad Sci U S A (1984) 5.42

Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem (1969) 5.35

Each of three "TATA elements" specifies a subset of the transcription initiation sites at the CYC-1 promoter of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1985) 4.69

Hyperthermia in combined treatment of cancer. Lancet Oncol (2002) 4.41

Connections between single-cell biomechanics and human disease states: gastrointestinal cancer and malaria. Acta Biomater (2005) 4.22

Analysis of the induction of general stress proteins of Bacillus subtilis. Microbiology (1994) 4.16

P-TEFb kinase recruitment and function at heat shock loci. Genes Dev (2000) 4.07

Function of a yeast TATA element-binding protein in a mammalian transcription system. Nature (1988) 3.91

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89

High-resolution localization of Drosophila Spt5 and Spt6 at heat shock genes in vivo: roles in promoter proximal pausing and transcription elongation. Genes Dev (2000) 3.79

A transcription reinitiation intermediate that is stabilized by activator. Nature (2000) 3.65

A prospective randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaging induce a learning effect? Gut (2007) 3.60

Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer. J Clin Oncol (2004) 3.56

European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56

Crystal structure of the yeast TFIIA/TBP/DNA complex. Science (1996) 3.45

Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism. Genes Dev (1994) 3.45

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology (2001) 3.26

RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med (1992) 3.25

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet (1994) 3.24

Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res (2001) 3.23

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res (1997) 3.17

On the validity of the Beck Depression Inventory. A review. Psychopathology (1998) 3.16

Transient accumulation of potassium glutamate and its replacement by trehalose during adaptation of growing cells of Escherichia coli K-12 to elevated sodium chloride concentrations. Arch Microbiol (1988) 3.12

CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J (1998) 3.06

Retracted Long-term results and risk factors influencing outcome of major bile duct injuries following cholecystectomy. Br J Surg (2005) 3.06

Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics (2001) 3.05

The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials (2005) 2.98

Transport route for synaptobrevin via a novel pathway of insertion into the endoplasmic reticulum membrane. EMBO J (1995) 2.96

Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB. Genes Dev (1999) 2.94

Clathrin-coated vesicles contain an ATP-dependent proton pump. Proc Natl Acad Sci U S A (1983) 2.84

A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell (1988) 2.84

Endoscopically assisted video capsule endoscopy of the small bowel in patients with functional gastric outlet obstruction. Endoscopy (2003) 2.82

Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet (1995) 2.81

Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study. Endoscopy (2013) 2.76

Variants of the TATA-binding protein can distinguish subsets of RNA polymerase I, II, and III promoters. Cell (1992) 2.76

Yeast HAP2 and HAP3 activators both bind to the CYC1 upstream activation site, UAS2, in an interdependent manner. Cell (1987) 2.73

The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev (1998) 2.72

The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis (2001) 2.71

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70

The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB. Cell (1992) 2.69

Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract (1998) 2.63

Regulation of sigmaB-dependent transcription of sigB and asp23 in two different Staphylococcus aureus strains. Mol Gen Genet (1999) 2.62

Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol (1995) 2.57

Improving depression outcomes in community primary care practice: a randomized trial of the quEST intervention. Quality Enhancement by Strategic Teaming. J Gen Intern Med (2001) 2.56

Multiple extracellular signals are required for long-term oligodendrocyte survival. Development (1993) 2.55

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol (2004) 2.54

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49

Recruitment of the SWI/SNF chromatin remodeling complex by transcriptional activators. Genes Dev (1999) 2.48

Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol (1994) 2.41

Incisional hernia rate 3 years after midline laparotomy. Br J Surg (2013) 2.37

Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36

Sexual segregation in ungulates: a comparative test of three hypotheses. Biol Rev Camb Philos Soc (2002) 2.34

The enzymatic formation of bilirubin. Ann N Y Acad Sci (1975) 2.34

The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin. J Lab Clin Med (1970) 2.32

Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res (2001) 2.29

Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology (1993) 2.29

A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24

Palliative endoscopic therapy of rectal carcinoma. Eur J Cancer (1996) 2.22

Task coordination and aging: explorations of executive control processes in the task switching paradigm. Acta Psychol (Amst) (1999) 2.22

The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics (2001) 2.21

General and oxidative stress responses in Bacillus subtilis: cloning, expression, and mutation of the alkyl hydroperoxide reductase operon. J Bacteriol (1996) 2.20

An ATP-dependent inhibitor of TBP binding to DNA. Genes Dev (1993) 2.19

Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. J Clin Oncol (2005) 2.19

A yeast TFIIB-related factor involved in RNA polymerase III transcription. Genes Dev (1992) 2.17

The impact of carbon dioxide pneumoperitoneum on liver regeneration after liver resection in a rat model. Surg Endosc (2009) 2.16

Frequency-domain techniques enhance optical mammography: initial clinical results. Proc Natl Acad Sci U S A (1997) 2.15

Current status of screening colonoscopy in Europe and in the United States. Endoscopy (2007) 2.14

Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13

Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy (2004) 2.07

Rectal cancer : when is the local recurrence risk low enough to refrain from the aim to prevent it? Strahlenther Onkol (2013) 2.06

The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta (1995) 2.06

Expression of a stress- and starvation-induced dps/pexB-homologous gene is controlled by the alternative sigma factor sigmaB in Bacillus subtilis. J Bacteriol (1997) 2.03

[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03

Management of acute pancreatitis: from surgery to interventional intensive care. Gut (2005) 2.02

Characterization of the sigma(B) regulon in Staphylococcus aureus. J Bacteriol (2000) 2.00

Mediator, not holoenzyme, is directly recruited to the heat shock promoter by HSF upon heat shock. Mol Cell (2001) 2.00

Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology (1998) 1.98

Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa. Gut (1999) 1.97

Third consensus on medical treatment of metastatic breast cancer. Ann Oncol (2009) 1.96

Hepatitis B viral DNA in liver and serum of asymptomatic carriers. Proc Natl Acad Sci U S A (1982) 1.96

Catabolism of heme in vivo: comparison of the simultaneous production of bilirubin and carbon monoxide. J Clin Invest (1970) 1.96

Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy. J Hepatol (2010) 1.95

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer (2004) 1.94

First steps from a two-dimensional protein index towards a response-regulation map for Bacillus subtilis. Electrophoresis (1997) 1.91

Dominant negative mutations in yeast TFIID define a bipartite DNA-binding region. Cell (1991) 1.91

STUDIES IN THE PHYSIOLOGY OF ARTIFICIAL FEVER. I. CHANGES IN THE BLOOD VOLUME AND WATER BALANCE. J Clin Invest (1938) 1.91

Stress proteins and cross-protection by heat shock and salt stress in Bacillus subtilis. J Gen Microbiol (1992) 1.91

Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. Cancer Res (2000) 1.90

Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc (2001) 1.90

Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis. Diabetologia (2013) 1.88